Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Mycosis Fungoides × cemiplimab × Clear all

Phase

Status

Recruiting 2 Withdrawn 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Squamous Cell Carcinoma of Head and Neck 1 Prostatic Neoplasms 1 Oropharyngeal Neoplasms 1 Mycosis Fungoides 1 Lung Neoplasms 1 Hodgkin Disease 1 Head and Neck Neoplasms 1 Carcinoma, Squamous Cell 1 Carcinoma, Non-Small-Cell Lung 1 Brain Neoplasms 1 Advanced Malignancies 1

Interventions

Peripheral Blood Stem Cell Transplantation 4 Cyclophosphamide 4 fludarabine phosphate 3 Cytarabine 3 Whole-Body Irradiation 2 Vorinostat 2 Tacrolimus 2 Pentetic Acid 2 Mycophenolic Acid 2 Methotrexate 2 Bortezomib 2 sargramostim 1 pembrolizumab 1 fludarabine 1 ethanolamine oleate 1 denileukin diftitox 1 cemiplimab 1 Vincristine 1 Trimethoprim, Sulfamethoxazole Drug Combination 1 Trimethoprim 1 Transplantation 1 Thiotepa 1 Therapeutics 1 Surveys and Questionnaires 1 Sulfamethoxazole 1 Sodium Chloride 1 Saline Solution, Hypertonic 1 Saline Solution 1 Radiotherapy 1 Psychiatric Rehabilitation 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05538988 2025-06-27

BIOSELECT

AHS Cancer Control Alberta

Phase 1/2 Withdrawn

Mycosis Fungoides

Data powered by HemOnc (CC BY 4.0) Colophon ⚡